{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T19:45:49Z","timestamp":1772653549886,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":850,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1093\/annonc\/mdx164","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T07:49:01Z","timestamp":1492674541000},"page":"1582-1589","source":"Crossref","is-referenced-by-count":17,"title":["Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors"],"prefix":"10.1016","volume":"28","author":[{"given":"C.","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.M.","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.T.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdx164_bb0010","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx164_bb0015","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/00004836-200608000-00003","article-title":"Gastrointestinal carcinoids: the evolution of diagnostic strategies","volume":"40","author":"Modlin","year":"2006","journal-title":"J Clin Gastroenterol"},{"key":"10.1093\/annonc\/mdx164_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.6004\/jnccn.2015.0011","article-title":"Neuroendocrine tumors, version 1.2015","volume":"13","author":"Kulke","year":"2015","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1093\/annonc\/mdx164_bb0025","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/MPA.0b013e31828e34a4","article-title":"Consensus guidelines for the management and treatment of neuroendocrine tumors","volume":"42","author":"Kunz","year":"2013","journal-title":"Pancreas"},{"key":"10.1093\/annonc\/mdx164_bb0030","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1200\/JCO.2010.33.2056","article-title":"Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting","volume":"29","author":"Kulke","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdx164_bb0035","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.ejca.2011.10.030","article-title":"Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections","volume":"48","author":"Boninsegna","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdx164_bb0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000217604","article-title":"Are there prognostic factors related to recurrence in pancreatic endocrine tumors?","volume":"10","author":"Casadei","year":"2010","journal-title":"Pancreatology"},{"key":"10.1093\/annonc\/mdx164_bb0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/COC.0b013e31821dee0f","article-title":"Clinical course of neuroendocrine tumors with different origins (the pancreas, gastrointestinal tract, and lung)","volume":"35","author":"Kim","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"10.1093\/annonc\/mdx164_bb0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/SLA.0b013e31824e6108","article-title":"Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications","volume":"256","author":"Strosberg","year":"2012","journal-title":"Ann Surg"},{"key":"10.1093\/annonc\/mdx164_bb0055","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/ERC-12-0340","article-title":"Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database","volume":"20","author":"Ter-Minassian","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1093\/annonc\/mdx164_bb0060","unstructured":"National Cancer Institute: Surveillance, Epidemiology and End Results (SEER), 2015; http:\/\/seer.cancer.gov\/about\/overview.html (27 April 2017, date last accessed)."},{"key":"10.1093\/annonc\/mdx164_bb0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.anndiagpath.2015.01.001","article-title":"Comparison of World Health Organization 2000\/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors","volume":"19","author":"Pasaoglu","year":"2015","journal-title":"Ann Diagn Pathol"},{"key":"10.1093\/annonc\/mdx164_bb0070","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1470-2045(17)30110-9","article-title":"Frequency of carcinoid syndrome at neuroendocrine tumour diagnosis: a population-based study","volume":"18","author":"Halperin","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdx164_bb0075","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/MLR.0b013e318277eb6f","article-title":"Validating billing\/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts","volume":"52","author":"Hassett","year":"2014","journal-title":"Med Care"},{"key":"10.1093\/annonc\/mdx164_bb0080","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/jnci\/djj363","article-title":"Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)","volume":"98","author":"Lamont","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdx164_bb0085","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdx164_bb0090","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/cncr.28653","article-title":"Octreotide long-acting repeatable use among elderly patients with carcinoid syndrome and survival outcomes: a population-based analysis","volume":"120","author":"Shen","year":"2014","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdx164_bb0095","series-title":"NANETS Symposium Jackson Wyoming","article-title":"Incidence and prevalence of neuroendocrine tumors in the United States 1973\u20132012","author":"Shen","year":"2016"},{"key":"10.1093\/annonc\/mdx164_bb0100","series-title":"NANETS Symposium, Jackson Wyoming","article-title":"Survival trends of neuroendocrine tumors and associated prognostic factors","author":"Dasari","year":"2016"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419322616?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419322616?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/28\/7\/1582\/17928092\/mdx164.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T08:24:24Z","timestamp":1624695864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419322616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0923753419322616"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdx164","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}